SCHEMBL6689196

SCHEMBL6689196

COC(=O)c1cccc2c1c1c(O)cc(C)cc1n2Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
MAPT P10636 2/20 0.47
ALDH1A1 P00352 2/20 0.47
PKM P14618 1/20 0.47
PLA2G2A P14555 6/20 0.44
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.43
THRB P10828 1/20 0.42
AR P10275 1/20 0.42
NOTUM Q6P988 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
PLA2G10 O15496 1/20 0.41
PLA2G1B P04054 1/20 0.41
PLA2G5 P39877 1/20 0.41
PLA2G2E Q9NZK7 1/20 0.41
MAPK8 P45983 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6889571 0.93 PLA2G2A (0.44) GAAMAPTALDH1A1PKMPLA2G2A
SCHEMBL6894729 0.93 MAPT (0.41) GAAMAPTALDH1A1PKMPLA2G2A
SCHEMBL6691521 0.92 MAPT (0.49) GAAMAPTALDH1A1PKMNPSR1
SCHEMBL6889588 0.92 PLA2G2A (0.49) GAAMAPTALDH1A1PKMPLA2G2A
SCHEMBL6896220 0.91 FAAH (0.43) GAAMAPTALDH1A1PKMTHRB
SCHEMBL6888834 0.91 HSP90AA1 (0.41) GAAMAPTALDH1A1PKMPLA2G2A
SCHEMBL6688534 0.89 MAPT (0.45) GAAMAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6897569 0.89 MAPT (0.40) GAAMAPTALDH1A1PKMNPSR1
SCHEMBL6694644 0.89 AR (0.45) GAAMAPTALDH1A1PKMPLA2G2A
SCHEMBL6894814 0.89 MAPT (0.44) GAAMAPTALDH1A1PKMPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395554-B1 SUBSTITUTED CARBAZOLES AS INHIBITORS OF SPLA2 LILLY CO ELI (US) 2007-02-14 EP disclosed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed